Vanguard Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Vanguard Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,565,044	Closed	-$71.8M	–	4465
2024 Q1	$71.8M	Buy	4,565,044 +163,408	+4%	+$2.57M	﹤0.01%	2018
2023 Q4	$71M	Buy	4,401,636 +33,203	+0.8%	+$536K	﹤0.01%	2035
2023 Q3	$55.6M	Sell	4,368,433 -23,837	-0.5%	-$303K	﹤0.01%	2080
2023 Q2	$61.8M	Sell	4,392,270 -218,820	-5%	-$3.08M	﹤0.01%	2091
2023 Q1	$71.2M	Sell	4,611,090 -134,231	-3%	-$2.07M	﹤0.01%	2002
2022 Q4	$77.8M	Sell	4,745,321 -49,672	-1%	-$814K	﹤0.01%	1945
2022 Q3	$88.7M	Buy	4,794,993 +402,047	+9%	+$7.44M	﹤0.01%	1863
2022 Q2	$57.8M	Buy	4,392,946 +798,434	+22%	+$10.5M	﹤0.01%	2129
2022 Q1	$33.3M	Buy	3,594,512 +125,195	+4%	+$1.16M	﹤0.01%	2521
2021 Q4	$33.9M	Sell	3,469,317 -467,068	-12%	-$4.56M	﹤0.01%	2560
2021 Q3	$134M	Buy	3,936,385 +8,681	+0.2%	+$295K	﹤0.01%	1817
2021 Q2	$144M	Sell	3,927,704 -20,358	-0.5%	-$745K	﹤0.01%	1810
2021 Q1	$177M	Buy	3,948,062 +112,304	+3%	+$5.04M	﹤0.01%	1649
2020 Q4	$219M	Buy	3,835,758 +61,497	+2%	+$3.51M	0.01%	1412
2020 Q3	$194M	Buy	3,774,261 +224,700	+6%	+$11.5M	0.01%	1303
2020 Q2	$212M	Buy	3,549,561 +1,034,589	+41%	+$61.8M	0.01%	1239
2020 Q1	$104M	Buy	2,514,972 +314,211	+14%	+$12.9M	﹤0.01%	1508
2019 Q4	$137M	Buy	2,200,761 +757,527	+52%	+$47.1M	﹤0.01%	1594
2019 Q3	$49M	Buy	1,443,234 +650,580	+82%	+$22.1M	﹤0.01%	2076
2019 Q2	$17.9M	Buy	792,654 +20,252	+3%	+$457K	﹤0.01%	2568
2019 Q1	$17.9M	Buy	772,402 +59,240	+8%	+$1.37M	﹤0.01%	2555
2018 Q4	$15M	Buy	713,162 +37,645	+6%	+$790K	﹤0.01%	2579
2018 Q3	$26.2M	Buy	675,517 +14,081	+2%	+$545K	﹤0.01%	2459
2018 Q2	$26M	Buy	661,436 +335,553	+103%	+$13.2M	﹤0.01%	2448
2018 Q1	$6.53M	Buy	325,883 +35,225	+12%	+$706K	﹤0.01%	3034
2017 Q4	$6.59M	Buy	290,658 +108,658	+60%	+$2.46M	﹤0.01%	3022
2017 Q3	$3.46M	Buy	+182,000	New	+$3.46M	﹤0.01%	3244